Smite Aija practice in Dermatology
- Address
- lock Available on a paid plan
Smite Aija Practice - Dermatology Research Center
Smite Aija Practice is a specialized dermatology research center focused on advancing treatment options for chronic inflammatory skin conditions. The practice demonstrates particular expertise in conducting complex clinical investigations for immune-mediated dermatological disorders, with a strong emphasis on evaluating novel therapeutic agents through rigorous Phase 3 clinical trial protocols.
- Moderate to severe plaque psoriasis treatment development
- Long-term safety and efficacy assessment of innovative biologics
- Placebo-controlled and active comparator dermatology trials
The center's research portfolio includes participation in the comprehensive ONWARD clinical trial program, evaluating ESK-001 as an investigational treatment for moderate to severe plaque psoriasis. Their involvement in both efficacy-focused Phase 3 studies and long-term extension trials demonstrates a commitment to understanding both the immediate therapeutic benefits and sustained safety profiles of emerging dermatological therapies, providing patients access to cutting-edge treatment options while contributing valuable data to advance the field of psoriasis management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Alumis Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 80 other sites in Latvia
Therapeutic Area Benchmark — Latvia
Select a therapeutic area to compare against other sites in Latvia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Latvia
Market Share
Country: Latvia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Smite Aija practice in Dermatology
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Ignite) | Amgen Inc. | Phase III | Not Recruiting | Apr 2023 | Sep 2024 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apremilast | 2 | Unknown | 2024-05-07 | 2025-02-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.